The aim of the study is to determine if Iressa added to radiotherapy is effective and safe in shrinking tumour dimensions.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
28
Research Site
Aviano, Italy
Research Site
Azienda, Italy
Research Site
Milan, Italy
Research Site
Napoli, Italy
Research Site
Palermo, Italy
Tumour Response Rate, as complete response (CR) and partial response (PR) . Six months after Last Patient In.
Time to progression, Overall survival, Duration of response. Six months after Last Patient In.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Research Site
Ragusa, Italy